While most of these alterations are also seen in other autoimmune or neurodegenerative disorders, we find that the decrease in plasma granzyme A, a serine protease released by NK cells as part of the degranulation response, is relatively specific to MS and is not explained by treatment with interferon. The gene discussed is GZMA; the disease is myeloid sarcoma.